This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

2024 ASCO® Annual Meeting Insights Hub
C

ASCO® 2024 Summary: "Treatment Considerations for Challenging Populations With Hodgkin Lymphoma"

By 2024 ASCO® Annual Meeting Insights Hub FEATURING Cathy Burton
By 2024 ASCO® Annual Meeting Insights Hub FEATURING Cathy Burton
91 views
June 10, 2024

Chapters

Overview & Focus on Older Patients

00:00

Biology & Challenges in Older Patients

01:40

Chemotherapy & Bleomycin Concerns

02:44

Targeted Treatments & Brentuximab Trials

03:56

Efficacy of Brentuximab & Nivolumab

05:48

Treatment Strategies for Unfit & Comorbid Patients

12:27

Conclusions & Future Directions

15:16

0 Comments
Login to view comments. Click here to Login

Featured Video

37:21
Amgen Sponsorship

New Approval for Frontline Consolidation in Patients with CD19-posit…

Feat. J. Mccloskey

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison

2024 ASCO® Annual Meeting Insights Hub: Hematologic Oncology Videos

06:26
ecancer

Post-Transplant Cyclophosphamide Based GVHD Prophylaxis in Patients …

Feat. M. Al Malki, S. Devine
09:04
ecancer

ASCO® 2024 Insights: "Importance of MRD in Newly Diagnosed Mult…

Feat. X. Leleu
27:49
Insights from 2024 EHA Annual Meeting

AML, MDS, and CML Highlights & Key Takeaways From ASCO®/EHA 2024

Feat. T. Badar
View All

Related Content

AUTOPLAY
21:05
Louisville Hematology Highlights

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Feat. R. Gale
10:52
University of Miami Sylvester Comprehensive Cancer Center

Current Treatment of 1L Hodgkin Lymphoma

Feat. C. Moskowitz
12:49
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Treatment of Relapsed HL - Updated Options…

Feat. P. Johnson
24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray
21:56
Indy Hematology Review

Emerging and Current Treatment for Hodgkin Lymphoma in 2024

Feat. S. Ansell
11:12
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "SWOG S1826, a Randomized Study of Nivo-AV…

Feat. A. Herrera
31:12
UChicago Medicine

Practice-Changing Abstracts in NHL and HL From ASH 2023

Feat. S. Smith
16:34
Jennifer Amengual

Top 5 Lymphoma Abstracts From ASH

29:26
Massachusetts General Hospital Cancer Center

Practice-Changing Updates in DLBCL and HL

Feat. J. Erika Haydu
18:24
Memorial Sloan Kettering Cancer Center

Key Lymphoma Updates From ASH

Feat. P. Torka
15:47
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "SWOG S1826 - Rationale, Results, and Clin…

Feat. A. Evens
20:49
SOHO Brazil 2024

Summary of Recent Updates in Advanced Hodgkin Lymphoma

Feat. C. Moskowitz
28:11
Total Health

Hematologic Malignancies Update: Treatment Strategies for AML, DLBCL…

Feat. M. Rotta
10:04
Stephen M. Ansell

NCCN Guidelines for the Treatment of cHL: A New Standard of Care

26:43
Integrity CE

Treatment Updates and Management of Hodgkin Lymphoma

Feat. A. Niu, D. Wallace, M. Cortese
18:06
SOHO Brazil 2024

Summary of Recent Updates in R/R HL

Feat. C. Moskowitz
14:47
Insights from 2024 EHA Annual Meeting

EHA 2024 Insights: Treatment of Advanced Stage, High-Risk Hodgkin&#x…

Feat. M. Salamoon
40:21
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course

Overview of Hematopoietic Cell Transplantation

Feat. R. Salit
12:09
Pooja Khandelwal

Treating Fibrosis and Inflammation in GvHD

17:51
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Chronic GVHD: A Case-Based Discussion

Feat. L. Perry